Here Are the Facts You Need to Understand NEOG

By Scott Lee • Wednesday, September 06 09:52 • Permanent Link

Join us for a quick overview of Neogen, a Biotechnology company whose shares moved -0.2% today. Here are some facts about the stock that should help you see the bigger picture:

Neogen has moved 24.0% over the last year, and the S&P 500 logged a change of 14.0%
NEOG has an average analyst rating of buy and is -15.54% away from its mean target price of $26.0 per share
Its trailing earnings per share (EPS) is $-0.12
Neogen has a trailing 12 month Price to Earnings (P/E) ratio of -183.0 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $0.75 and its forward P/E ratio is 29.3
The company has a Price to Book (P/B) ratio of 1.52 in contrast to the S&P 500's average ratio of 2.95
Neogen is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
NEOG has reported YOY quarterly earnings growth of -81.4% and gross profit margins of 0.5%
The company has a free cash flow of $35.64 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.